Scientists grow human heart tissue

(PARIS-AFP) - Scientists said Tuesday they had used stem cells to grow human heart tissue that contracted spontaneously in a petri dish -- marking progress in the quest to manufacture transplant organs.

A team from the University of Pittsburgh, Pennsylvania, used induced pluripotent stem (iPS) cells generated from human skin cells to create precursor heart cells called MCPs.

iPS cells are mature human cells "reprogrammed" into a versatile, primitive state from which they can be prompted to develop into any kind of cell of the body.The primitive heart cells created in this way were attached to a mouse heart "scaffold" from which the researchers had removed all mouse heart cells, they wrote in the journal Nature Communications. The scaffold is a network of non-living tissue composed of proteins and carbohydrates to which cells adhere and grow on.

Vitamin B17 Biji Aprikot Anti Kanser

Klik gambar di atas untuk pesanan / pembelian

Vitamin B17 dikatakan mampu merawat & mencegah kanser. Bagi sesetengah individu agak sukar untuk mempercayainya. Namun, sebenarnya Vitamin B17 ini telah lama ditemui dan terbukti mampu membantu terapi kanser.

Vitamin B17 adalah penawar semulajadi yang terdapat pada lebih 1200 jenis tumbuh-tumbuhan, buah-buahan dan bijirin terutamanya Biji Aprikot.

Malangnya tabiat pemakanan kita hari ini tidak suka kepada rasa yang agak pahit seperti Vitamin B17 yang rasanya agak pahit tetapi sebenarnya amat berkesan untuk mencegah kanser.

Biji Aprikot

Makan biji Aprikot untuk menjaga kesihatan kita sekeluarga.

Dr Ernest Kreb Jr, Pakar Biochemist, Pengasas Vitamin B15 dan B17: “B17 adalah harapan utama dan terakhir di dalam terapi kanser”.

“Tidaklah ALLAH menurunkan sesuatu penyakit, melainkan DIA menurunkan ubat baginya” - Ibnu Maajah.

World's 1st dengue vaccine beats 3 virus strains in clinical trial

A man suffering from dengue fever, sits under a mosquito net while seeking treatment at the Services Hospital in Lahore, in this file picture taken on Sep 18, 2011. The world's first vaccine against dengue, developed by French drugmaker Sanofi, has shown the ability to protect against disease caused by three of four dengue virus strains in a keenly awaited clinical trial in Thailand. -- PHOTO: REUTERS

PARIS (REUTERS) - The world's first vaccine against dengue, developed by French drugmaker Sanofi, has shown the ability to protect against disease caused by three of four dengue virus strains in a keenly awaited clinical trial in Thailand.

Sanofi said on Wednesday the proof of efficacy was 'a key milestone' in the 70-year quest to develop a viable dengue shot, adding the results also confirmed the safety profile of the vaccine candidate.